在多发性硬化症相关的性症中,纳比西莫尔治疗患者报告的益处超过了传统措施
Michael R Haupts1, Ute Essner2, Mathias Mäurer3
1Department of Neurology, Heinrich Heine University Düsseldorf, Düsseldorf, 40225, Germany.
Neurodegenerative disease management
|February 6, 2024
概括
在德国的一项真实研究中,纳比西莫尔斯口腔粘膜喷雾有效改善了多发性硬化症 (MS) 性,疼痛和睡眠. 这种治疗选择对患有MS性的患者有显著的益处.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 多发性硬化症 (MS) 性显著影响患者的生活质量.
- 对于MS性的现有治疗方法有局限性.
- 纳比西莫尔 (Sativex®) 是一种用于治疗MS性的口腔粘膜喷雾剂.
研究的目的:
- 评估MS性在德国患者中添加纳比西莫尔的现实有效性和耐受性.
- 评估性,疼痛,睡眠和尿路功能障碍的变化.
- 确定在接受纳比西莫尔的患者中实现的总体目标.
主要方法:
- 展望性,多中心,开放式,非干预性的12周研究.
- 包括51名患有MS性的成年患者.
- 纳比克西摩尔或菌喷雾作为一种附加疗法.
主要成果:
- 从基线到第12周的总体目标实现规模得分显著改善了46% (p < 0.001).
- 在第4周和第12周,平均步行速度提高了23%.
- 观察到临床上有意义的性,疼痛,睡眠障碍和泌尿膀功能障碍的减少.
结论:
- 纳比西莫尔是一种有价值的治疗选择,用于在现实世界中管理多发性硬化症性.
- 这项研究支持纳比西莫尔在改善多发性硬化症症状方面的有效性和耐受性.
- 在MS患者中,纳比西莫尔在多种症状领域表现出积极的结果.
关键词:
目标实现规模 目标实现规模多发性硬化症多发性硬化症纳比克西莫尔或菌喷雾剂患者报告的结果.性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性,性等.更多相关视频
03:26Author Spotlight: Advancements and Challenges in Surgical Treatments for Postamputation Pain
Published on: March 8, 2024
2.6K
06:28Biomechanical Changes Related to Low Back Pain: An Innovative Tool for Movement Pattern Assessment and Treatment Evaluation in Rehabilitation
Published on: December 13, 2024
508
相关概念视频
Skeletal Muscle Relaxants: Therapeutic Uses
487
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
487
Centrally Acting Muscle Relaxants: Therapeutic Uses
690
Centrally acting muscle relaxants reduce muscle tone and tension by interfering with the postsynaptic reflexes in the central nervous system.
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
Centrally acting drugs are classified into spasmolytic and antispasmodic drugs. Spasmolytic drugs such as baclofen, diazepam, and tizanidine inhibit spinal motor neurons and decrease muscle tone. Spasmolytic drugs are administered for severe and chronic spasms due to multiple sclerosis, cerebral palsy, stroke, and spinal cord and muscle injuries. However,...
690
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
